Contact
Please use this form to send email to PR contact of this press release:
Foamix Announces Enrollment of First Patient in Phase 2 Clinical Trial of FMX103 in Papulopustular Rosacea
TO:
Please use this form to send email to PR contact of this press release:
Foamix Announces Enrollment of First Patient in Phase 2 Clinical Trial of FMX103 in Papulopustular Rosacea
TO: